Rising research expenditure to detect the toxicity at the earliest possible stage is accelerating the in vitro toxicity testing market size over the forecast time span. Additionally, technological innovations in computational biology accompanied with advanced algorithms aid in conducting efficient stimulation of in-silico animal models, resulting in alternatives to animal testing. This will certainly gain momentum for clinical studies and support in industry growth over the coming years.
The In Vitro Toxicity Testing Market is expected to reach US$ 18.60 billion by 2028 at a CAGR of 10%
Globally, shifting trend of non-animal tests together with implementation of government rules and regulations for alternate test assays aimed at preliminary clinical studies and toxicology testing is predicted to offer growth opportunities for the in vitro toxicity testing business size over the estimated period.
Global in vitro toxicity testing market is segregated on the basis of technology as, Cell-Culture, High Throughput, Molecular Imaging, and OMICS Technology. The industry is divided by method which includes Cellular Assays, Biochemical Assays, In-silico, and Ex-vivo. Based on application, the global in vitro toxicity testing market is segmented as Systemic Toxicology, Dermal Toxicity, Endocrine Disruption, and Occular Toxicity. The report also bifurcates global in vitro toxicity testing market based on end-use as Pharmaceutical & Biopharmaceutical, Cosmetics & Household Products, Food, and Chemical.
Global in vitro toxicity testing market report provides geographic analysis covering regions such as North America, Europe, Asia Pacific, and Rest of World. The in vitro toxicity testing market for each region is further segmented for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
SGS, Covance, Bio-Rad Laboratories, Qiagen, GE Healthcare, Eurofins Scientific, Merck Group, Thermo Fisher Scientific, Charles River Laboratories International, and Catalent are among the major players in the global in vitro toxicity testing market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The In Vitro Toxicity Testing Market has been segmented as below:
In Vitro Toxicity Testing Market, By Technology
In Vitro Toxicity Testing Market, By Method
In Vitro Toxicity Testing Market, By Application
In Vitro Toxicity Testing Market, By End-Use
In Vitro Toxicity Testing Market, By Region
The report covers:
Report scope:
Global in vitro toxicity testing market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global in vitro toxicity testing market share. Major industry players with significant revenue share inlcude SGS, Covance, Bio-Rad Laboratories, Qiagen, GE Healthcare, Eurofins Scientific, Merck Group, Thermo Fisher Scientific, Charles River Laboratories International, and Catalent.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
Medical non-woven disposable market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Technological advancements for in vitro
4.2.2. Increasing R&D expenditures
4.2.3. Opposition for animal testing
4.3. Restraints
4.3.1. Failure to establish intricacies of in vivo conditions through in vitro
4.3.2. Lack of in vitro models to study complex endpoints
4.4. Opportunities
4.4.1. Increasing drug discovery
4.4.2. Increasing toxicology databases will facilitate the use of in vitro test methods
4.5. Challenges
4.5.1. Dearth of skilled professionals
5. In Vitro Toxicity Testing Market, By Technology
5.1. Key Points
5.2. Cell Culture Tech
5.3. High Throughput Tech
5.4. Molecular Imaging
5.5. OMICS Tech
6. In Vitro Toxicity Testing Market, By Method
6.1. Key Points
6.2. Cellular Assay
6.3. Biochemical Assay
6.4. In Silica
6.5. Ex-vivo
7. In Vitro Toxicity Testing Market, By Application
7.1. Key Points
7.2. Systemic Toxicology
7.3. Dermal Toxicity
7.4. Endorine Disruption
7.5. Occular Toxicity
8. In Vitro Toxicity Testing Market, By End-Use
8.1. Key Points
8.2. Pharmaceutical and Biopharmaceutical
8.3. Cosmetics and Household Products
8.4. Food
8.5. Chemical
9. Competitive Landscape
9.1. Introduction
9.2. Recent Developments
9.2.1. Mergers & Acquisitions
9.2.2. New Product Developments
9.2.3. Portfolio/Production Capacity Expansions
9.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
9.2.5. Others
10. Company Profile
10.1. SGS
10.1.1. Company Overview
10.1.2. Product/Service Landscape
10.1.3. Financial Overview
10.1.4. Recent Developments
10.2. Covance
10.2.1. Company Overview
10.2.2. Product/Service Landscape
10.2.3. Financial Overview
10.2.4. Recent Developments
10.3. Bio-Rad Laboratories
10.3.1. Company Overview
10.3.2. Product/Service Landscape
10.3.3. Financial Overview
10.3.4. Recent Developments
10.4. Qiagen
10.4.1. Company Overview
10.4.2. Product/Service Landscape
10.4.3. Financial Overview
10.4.4. Recent Developments
10.5. GE Healthcare
10.5.1. Company Overview
10.5.2. Product/Service Landscape
10.5.3. Financial Overview
10.5.4. Recent Developments
10.6. Eurofins Scientific
10.6.1. Company Overview
10.6.2. Product/Service Landscape
10.6.3. Financial Overview
10.6.4. Recent Developments
10.7. Merck Group
10.7.1. Company Overview
10.7.2. Product/Service Landscape
10.7.3. Financial Overview
10.7.4. Recent Developments
10.8. Thermo Fisher Scientific
10.8.1. Company Overview
10.8.2. Product/Service Landscape
10.8.3. Financial Overview
10.8.4. Recent Developments
10.9. Charles River Laboratories International
10.9.1. Company Overview
10.9.2. Product/Service Landscape
10.9.3. Financial Overview
10.9.4. Recent Developments
10.10. Catalent
10.10.1. Company Overview
10.10.2. Product/Service Landscape
10.10.3. Financial Overview
10.10.4. Recent Developments
The In Vitro Toxicity Testing Market has been segmented as below:
In Vitro Toxicity Testing Market, By Technology
In Vitro Toxicity Testing Market, By Method
In Vitro Toxicity Testing Market, By Application
In Vitro Toxicity Testing Market, By End-Use
In Vitro Toxicity Testing Market, By Region
